Clari Vest Asset Management LLC Enanta Pharmaceuticals Inc Transaction History

Clari Vest Asset Management LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 12, 2020	SELL	$57.95 - $66.61 $2.19 Million - $2.52 Million	-37,839 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$60.08 - $88.17 $907,208 - $1.33 Million	-15,100 Reduced 28.52%	37,839 $2.27 Million
Q2 2019 Aug 16, 2019	BUY	$81.3 - $97.35 $1.72 Million - $2.05 Million	21,096 Added 66.25%	52,939 $4.47 Million
Q1 2019 May 13, 2019	SELL	$69.08 - $105.66 $168,140 - $257,176	-2,434 Reduced 7.1%	31,843 $3.04 Million
Q4 2018 Feb 05, 2019	BUY	$65.41 - $84.65 $865,701 - $1.12 Million	13,235 Added 62.9%	34,277 $2.43 Million
Q3 2018 Nov 07, 2018	SELL	$85.46 - $126.37 $52,899 - $78,223	-619 Reduced 2.86%	21,042 $1.8 Million
Q2 2018 Aug 10, 2018	BUY	$81.85 - $120.51 $880,787 - $1.3 Million	10,761 Added 98.72%	21,661 $2.51 Million
Q1 2018 May 08, 2018	SELL	$57.91 - $92.15 $249,012 - $396,245	-4,300 Reduced 28.29%	10,900 $882,000
Q4 2017 Feb 13, 2018	BUY	$45.65 - $59.37 $77,605 - $100,929	1,700 Added 12.59%	15,200 $892,000
Q3 2017 Nov 07, 2017	BUY	$37.91 - $46.8 $3,790 - $4,680	100 Added 0.75%	13,500 $631,000
Q2 2017 Nov 20, 2017	BUY	N/A	13,400	13,400 $482,000

108

19.7M

9.7K

12.4K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $133M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Clari Vest Asset Management LLC with notifications on news.